RWA|Tax|Market|Longevity|Archive

Longevity Science Daily

Breakthroughs in anti-aging, regenerative medicine, genomics, and clinical trials

Report Date: 2026-07-15
80+
CRISPR Trials
6
CAR-T Approved
$7.2B
Longevity Market
14
FL Watchlist
Anti-Aging & Senolytics

TAME Trial: Metformin as Anti-Aging Drug

  • First FDA-recognized aging indication trial — 14 US research institutions, 6-year study
  • Targets whether metformin delays onset of age-related diseases

Senolytic Therapy: D+Q

  • Dasatinib + Quercetin selectively eliminates senescent cells
  • Unity Biotechnology UBX1325 in Phase 2 for age-related eye disease
CAR-T: Solid Tumor Breakthroughs

KIR-CAR T Cell Therapy (AACR 2026)

  • Novel KIR-CAR T demonstrates safety and dose-dependent efficacy in solid tumors
  • Universal (off-the-shelf) CAR-T could reduce cost from ~$500K to $50K
CRISPR & Gene Editing

80+ CRISPR Clinical Trials Active

  • Casgevy (Vertex/CRISPR): first approved CRISPR therapy, generating real-world evidence
  • Base editing (Beam Therapeutics): precision without double-strand breaks
  • In vivo LNP delivery (Intellia): durable gene knockdown — potential single-dose cures
Investment Signals
SignalCompanyThesis
ACCUMULATECRSPCasgevy revenue ramp + pipeline
ACCUMULATEVRTXCasgevy partner + CF franchise
SPECULATIVEBEAMBase editing platform
FL Intelligence Brief
Intelligence brief generation failed.
FL AI Intelligence Brief - 3 judgments + 1 action. Not investment advice.
FL Quant Signals - Top 10
TickerPriceSignalRSIMo1M%Mo3M%Mo12M%P/EBeta
JPM342.89BUY (3/7)60.50+9.9+10.7+21.916.00.98
GOOGL359.51HOLD (6/7)60.70+0.5+8.1+98.127.41.25
MSFT384.93HOLD (6/7)55.90-1.4-1.9-23.323.01.13
AAPL314.86HOLD (4/7)64.00+6.5+21.8+51.238.21.10
V356.02HOLD (3/7)71.60+11.6+14.6+3.431.00.75
0700.HK456.20HOLD (5/7)67.20-0.2-5.8-7.716.40.73
9988.HK110.80HOLD (5/7)67.90+3.2-10.0+4.517.40.50
1299.HK74.10HOLD (6/7)54.00+0.5-13.8+11.215.70.64
600519.SS1,214.88HOLD (6/7)60.20-3.7-13.8-11.218.40.38
000858.SZ73.40HOLD (5/7)50.40-8.2-28.3-38.622.40.39
48-factor quant screen: 5 US + 3 HK + 2 A-share. 8-strategy majority vote. Not investment advice.
AI Longevity Research Brief
Longevity commentary generation failed.
Generated by FL AI (GLM-4-Plus). Not medical or investment advice.
Cross-Domain Insights
1. RWA + Tax: Tokenized assets are now caught by CARF/CRS 2.0 reporting. Family offices holding tokenized treasuries must update CRS reporting to include on-chain positions. 3. Market + Longevity: Healthcare stocks (CRSP, VRTX, BEAM) show momentum alongside clinical breakthroughs. Consider biotech allocation. 4. Tax + Market: Global minimum tax (15%) reduces low-tax jurisdiction advantages. Reevaluate holding company locations.
FL AI scans all 4 daily reports for cross-domain connections. Not investment advice.
Cross-Domain Insights
CROSS-DOMAIN INSIGHTS BRIEFING 1. RWA Tokenization Meets Tax Transparency (RWA + Tax) The acceleration of real-world asset tokenization creates an immediate CRS/FATCA reporting gap. Tokenized securities held in self-custody wallets may not trigger traditional intermediary reporting. Action: Before allocating to any RWA platform, require written confirmation of how the issuer handles automatic information exchange. Prioritize platforms using permissioned chains where wallet-to-identity mapping is auditable. Family offices with cross-border structures should not assume tokenized assets fall under existing reporting frameworks. 2. Longevity Sector Rotation Signal (Market + Longevity) Biotech and longevity-focused equities typically outperform during late-cycle monetary easing when investors rotate into defensive growth. If the market report indicates dovish central bank signals, front-load positions in publicly traded longevity platforms (cell therapy, senolytics, biomarker diagnostics) before institutional capital crowds in. Pair this with private credit allocations to clinical-stage companies needing bridge funding between Phase II and III trials, where valuations are compressed but catalysts are near-term. 3. Tokenized Real Estate as Tax-Optimized Holding Vehicle (RWA + Tax + Market) Tokenized real estate vehicles may offer fractional exposure to commercial properties with embedded tax efficiency depending on jurisdiction of issuance. If the tax report flags changes to passive foreign investment company rules or controlled foreign corporation thresholds, tokenized real estate issued from compliant jurisdictions could serve as a restructuring tool. Action: Map current direct real estate holdings against tokenized alternatives to identify positions where migration reduces compliance burden without triggering disposition events. 4. Longevity Data Monetization Through RWA Infrastructure (Longevity + RWA) Genomic and longitudinal health data from longevity programs represents an emerging asset class. RWA infrastructure could tokenize individual health data pools, creating royalty-bearing instruments. Action: Explore partnerships with longevity clinics generating proprietary biomarker data to structure data-backed tokens, capturing value before larger platforms commoditize this space.
FL AI scans all 4 daily reports for cross-domain connections. Not investment advice.